Clinical Trial Update: Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating fremanezumab for migraine in women with menstrual migraine (ages 18-45); the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Migraine
• Menstrually Related Migraine
• Migraine

Drugs mentioned

• Fremanezumab (fremanezumab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Migraine, Menstrual Migraine | Phase 4 | Status: ACTIVE_NOT_RECRUITING